CN119053620A - 治疗传染病的新方法 - Google Patents

治疗传染病的新方法 Download PDF

Info

Publication number
CN119053620A
CN119053620A CN202380035128.9A CN202380035128A CN119053620A CN 119053620 A CN119053620 A CN 119053620A CN 202380035128 A CN202380035128 A CN 202380035128A CN 119053620 A CN119053620 A CN 119053620A
Authority
CN
China
Prior art keywords
peptide
angptl4
amino acid
protein
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202380035128.9A
Other languages
English (en)
Chinese (zh)
Inventor
S·布尔杜卢
J·齐韦里
L·勒盖内克
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Western Dais Paris, University of
Centre National de la Recherche Scientifique CNRS
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Western Dais Paris, University of
Centre National de la Recherche Scientifique CNRS
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Western Dais Paris, University of, Centre National de la Recherche Scientifique CNRS, Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Western Dais Paris, University of
Publication of CN119053620A publication Critical patent/CN119053620A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/515—Angiogenesic factors; Angiogenin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Vascular Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CN202380035128.9A 2022-03-16 2023-03-15 治疗传染病的新方法 Pending CN119053620A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP22305312 2022-03-16
EP22305312.5 2022-03-16
PCT/EP2023/056642 WO2023175022A1 (en) 2022-03-16 2023-03-15 New method to treat infectious diseases

Publications (1)

Publication Number Publication Date
CN119053620A true CN119053620A (zh) 2024-11-29

Family

ID=81324956

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202380035128.9A Pending CN119053620A (zh) 2022-03-16 2023-03-15 治疗传染病的新方法

Country Status (6)

Country Link
US (1) US20250163116A1 (https=)
EP (1) EP4493590A1 (https=)
JP (1) JP2025512749A (https=)
KR (1) KR20240159852A (https=)
CN (1) CN119053620A (https=)
WO (1) WO2023175022A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2023219197A1 (en) * 2022-02-14 2024-08-22 Sumant Singh CHUGH Methods of treating a cytokine storm related disease with recombinant mutated human angiopoietin-like 4
WO2025247922A1 (en) * 2024-05-28 2025-12-04 Institut National de la Santé et de la Recherche Médicale Use of the recombinant fibrinogen-like domain of angiopoietin-like 4 for treating sepsis capillary leak syndrome

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU643427B2 (en) 1988-10-31 1993-11-18 Immunex Corporation Interleukin-4 receptors
WO1991018982A1 (en) 1990-06-05 1991-12-12 Immunex Corporation Type ii interleukin-1 receptors
US6074849A (en) 1995-07-19 2000-06-13 Genetics Institute, Inc. Polynucleotides encoding human CTLA-8 related proteins
US6569645B2 (en) 1999-05-14 2003-05-27 Genentech, Inc. IL-17 homologous polypeptides and therapeutic uses thereof
US6579520B2 (en) 1998-05-15 2003-06-17 Genentech, Inc. IL-17 related mammalian cytokine polypeptides (IL-17E)
FR2827866B1 (fr) 2001-07-27 2004-12-10 Pasteur Institut Peptides synthetiques ou naturels liant la proteine phosphatase 2a, methode d'identification et utilisations
WO2004011595A2 (fr) 2002-07-26 2004-02-05 Institut Pasteur Vecteurs destines au transfert de molecules d'interet dans des cellules cibles
WO2011080132A2 (en) 2009-12-17 2011-07-07 Katholieke Universiteit Leuven, K.U. Leuven R&D Compounds, compositions and methods for controlling biofilms
WO2016020880A2 (en) * 2014-08-07 2016-02-11 Novartis Ag Angiopoietin-like 4 antibodies and methods of use
WO2016020882A2 (en) * 2014-08-07 2016-02-11 Novartis Ag Angiopoetin-like 4 (angptl4) antibodies and methods of use
US11446398B2 (en) * 2016-04-11 2022-09-20 Obsidian Therapeutics, Inc. Regulated biocircuit systems

Also Published As

Publication number Publication date
EP4493590A1 (en) 2025-01-22
JP2025512749A (ja) 2025-04-22
US20250163116A1 (en) 2025-05-22
KR20240159852A (ko) 2024-11-06
WO2023175022A1 (en) 2023-09-21

Similar Documents

Publication Publication Date Title
JP5322108B2 (ja) 抗菌ペプチド
CA2909080C (en) Methods, uses and compositions of tie2 agonists
JPH09508359A (ja) 抗グラム陽性細菌学的方法および物質
ES2381649T3 (es) Agentes antibacterianos que comprenden conjugados de glucopéptidos y elementos peptídicos asociados a la membrana
CN115379879A (zh) 用于预防和治疗纤维化疾病的抗Claudin-1单克隆抗体
CN119053620A (zh) 治疗传染病的新方法
US20100016242A1 (en) Myosin light chain kinase inhibitors and methods of use
JP6158097B2 (ja) 炎症を抑制するためのペプチド
JP2022023215A (ja) Ｄｐｅｐ－１結合組成物および使用の方法
CA2610791C (en) Hyaluronic acid binding peptides enhance host defense against pathogenic bacteria
Zheng et al. Supramolecular nanofibers ameliorate Bleomycin‐induced pulmonary fibrosis by restoring autophagy
CN101878302A (zh) 绿脓杆菌的外膜蛋白质pa4710
JPWO2007114340A1 (ja) 緑膿菌の外膜タンパク質ｐａ０４２７
US7824691B2 (en) Use of RIP in treating staphylococcus aureus infections
JP7792115B2 (ja) 感染症及び関連炎症プロセスの処置のための細菌結合ペプチド
US20220195072A1 (en) Targeted anticoagulant
CN103402531A (zh) 作为抗生素治疗的多价合成化合物
HRP20040127A2 (en) Peptidic compounds selectively binding top p-selection
JP6042106B2 (ja) メチオニン・スルホキシドを含む新規ポリペプチド
WO2022073134A1 (en) Annexin a5 compositions and methods
IL297703A (en) Homing peptide-guided decorin conjugates for use in treating epidermolysis bullosa
KR20210141667A (ko) 감염성 심내막염의 치료 방법
US20250352614A1 (en) Peptide therapeutics for the treatment of cancer and uses thereof
JP6578546B2 (ja) Ｌｔ阻害４価ペプチドおよびｅｔｅｃ感染症治療薬
CN112979764A (zh) 特异结合人cd47分子的多肽及其用途

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination